Deupirfenidone
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
PureTech
Overview
Deupirfenidone is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Deupirfenidone clinical trials
Explore related
Medical disclaimer. This page summarizes research about Deupirfenidone for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.